NO892512D0 - Oralt preparat av buspiron og salter derav. - Google Patents

Oralt preparat av buspiron og salter derav.

Info

Publication number: NO892512D0
Authority: NO; Norway
Prior art keywords: salts; buspiron; oral preparation; buspirone; bioavailability
Prior art date: 1987-10-22

Application number

NO892512A

Other languages

English (en)

Norwegian (no)

Other versions

NO892512L (no

Inventor

Alf Gunnar Martin Nicklasson

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-22

Filing date

1989-06-16

Publication date

1989-06-16

1989-06-16 Application filed by Astra Ab filed Critical Astra Ab

1989-06-16 Publication of NO892512L publication Critical patent/NO892512L/no

1989-06-16 Publication of NO892512D0 publication Critical patent/NO892512D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Plural Heterocyclic Compounds (AREA)

NO892512A 1987-10-22 1989-06-16 Oralt preparat av buspiron og salter derav. NO892512D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8704097A SE8704097D0 (sv)	1987-10-22	1987-10-22	Oral formulation of buspirone and salts thereof
PCT/SE1988/000543 WO1989003676A1 (fr)	1987-10-22	1988-10-17	Formulation orale de buspirone et de ses sels

Publications (2)

Publication Number	Publication Date
NO892512L NO892512L (no)	1989-06-16
NO892512D0 true NO892512D0 (no)	1989-06-16

Family

ID=20369959

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO892512A NO892512D0 (no)	1987-10-22	1989-06-16	Oralt preparat av buspiron og salter derav.

Country Status (21)

Country	Link
EP (1)	EP0313535B1 (fr)
JP (1)	JP2674170B2 (fr)
KR (1)	KR970004906B1 (fr)
AT (1)	ATE108997T1 (fr)
AU (1)	AU604585B2 (fr)
CY (1)	CY1814A (fr)
DE (1)	DE3850844T2 (fr)
DK (1)	DK294489D0 (fr)
ES (1)	ES2056955T3 (fr)
FI (1)	FI100303B (fr)
HK (1)	HK21295A (fr)
HU (1)	HU204998B (fr)
IE (1)	IE64705B1 (fr)
IL (1)	IL88020A (fr)
NO (1)	NO892512D0 (fr)
NZ (1)	NZ226604A (fr)
PT (1)	PT88820B (fr)
SE (1)	SE8704097D0 (fr)
WO (1)	WO1989003676A1 (fr)
YU (1)	YU47903B (fr)
ZA (1)	ZA887624B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU208495B (en) *	1990-06-27	1993-11-29	Alkaloida Vegyeszeti Gyar	Process for producing retarde pharmaceutical compositions
US5484788A (en) *	1993-03-26	1996-01-16	Beth Israel Hospital Association	Buspirone as a systemic immunosuppressant
US5631017A (en) *	1993-03-26	1997-05-20	Beth Israel Deaconess Medical Center, Inc.	Topical application of buspirone for treatment of pathological conditions associated with immune responses
DE4341156C2 (de) *	1993-12-02	1997-11-13	Wacker Chemie Gmbh	Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5478572A (en) *	1994-09-06	1995-12-26	Bristol-Myers Squibb Co.	Gepirone dosage form
US5637314A (en) *	1995-06-07	1997-06-10	Beth Israel Deaconess Medical Center, Inc.	Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) *	1997-03-24	1997-05-14	Scherer Ltd R P	Pharmaceutical composition
AU731693B2 (en) *	1997-09-25	2001-04-05	Bayer Intellectual Property Gmbh	Drug formulation having controlled release of active compound
US6268368B1 (en) *	2000-03-01	2001-07-31	American Pharmaceuticals International	Anionic exchange polymer complexes of buspirone
CN117257747B (zh) *	2023-11-21	2024-01-30	泊诺(天津)创新医药研究有限公司	一种盐酸丁螺环酮片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE759371A (fr) *	1969-11-24	1971-05-24	Bristol Myers Co	Azaspirodecanediones heterocycliques et procedes pour leur preparation
SE353229B (fr) *	1970-06-04	1973-01-29	Haessle Ab
US4182703A (en) *	1978-01-09	1980-01-08	Eastman Kodak Company	Biheterocyclic ultraviolet stabilizers and their use in organic compositions
US4182763A (en) *	1978-05-22	1980-01-08	Mead Johnson & Company	Buspirone anti-anxiety method
US4693895A (en) *	1984-10-26	1987-09-15	Alza Corporation	Colon delivery system
US4634703A (en) *	1985-10-25	1987-01-06	Bristol-Myers Company	Method for alleviation of panic disorders
US4640921A (en) *	1986-02-04	1987-02-03	Bristol-Myers	Treatment of sexual dysfunction with buspirone

1987
- 1987-10-22 SE SE8704097A patent/SE8704097D0/xx unknown
1988
- 1988-10-12 IL IL88020A patent/IL88020A/xx unknown
- 1988-10-12 ZA ZA887624A patent/ZA887624B/xx unknown
- 1988-10-17 ES ES88850347T patent/ES2056955T3/es not_active Expired - Lifetime
- 1988-10-17 WO PCT/SE1988/000543 patent/WO1989003676A1/fr not_active Ceased
- 1988-10-17 AT AT88850347T patent/ATE108997T1/de not_active IP Right Cessation
- 1988-10-17 AU AU26236/88A patent/AU604585B2/en not_active Ceased
- 1988-10-17 DE DE3850844T patent/DE3850844T2/de not_active Expired - Fee Related
- 1988-10-17 JP JP63508883A patent/JP2674170B2/ja not_active Expired - Fee Related
- 1988-10-17 KR KR1019890701101A patent/KR970004906B1/ko not_active Expired - Fee Related
- 1988-10-17 HU HU886266A patent/HU204998B/hu not_active IP Right Cessation
- 1988-10-17 EP EP88850347A patent/EP0313535B1/fr not_active Expired - Lifetime
- 1988-10-18 NZ NZ226604A patent/NZ226604A/en unknown
- 1988-10-20 IE IE317788A patent/IE64705B1/en not_active IP Right Cessation
- 1988-10-20 YU YU196488A patent/YU47903B/sh unknown
- 1988-10-21 PT PT88820A patent/PT88820B/pt active IP Right Revival
1989
- 1989-06-15 DK DK294489A patent/DK294489D0/da not_active Application Discontinuation
- 1989-06-16 NO NO892512A patent/NO892512D0/no unknown
- 1989-06-20 FI FI893017A patent/FI100303B/fi not_active IP Right Cessation
1995
- 1995-02-16 HK HK21295A patent/HK21295A/en not_active IP Right Cessation
- 1995-10-20 CY CY181495A patent/CY1814A/xx unknown

Also Published As

Publication number	Publication date
IL88020A0 (en)	1989-06-30
ATE108997T1 (de)	1994-08-15
DE3850844D1 (de)	1994-09-01
FI893017L (fi)	1989-06-20
CY1814A (en)	1995-10-20
DK294489A (da)	1989-06-15
ZA887624B (en)	1989-06-28
FI100303B (fi)	1997-11-14
PT88820B (pt)	1993-01-29
IE883177L (en)	1989-04-22
KR890701087A (ko)	1989-12-19
EP0313535A1 (fr)	1989-04-26
IE64705B1 (en)	1995-08-23
EP0313535B1 (fr)	1994-07-27
NZ226604A (en)	1991-07-26
WO1989003676A1 (fr)	1989-05-05
NO892512L (no)	1989-06-16
DK294489D0 (da)	1989-06-15
HK21295A (en)	1995-02-24
IL88020A (en)	1993-08-18
JPH02501744A (ja)	1990-06-14
YU196488A (en)	1990-04-30
ES2056955T3 (es)	1994-10-16
FI893017A0 (fi)	1989-06-20
KR970004906B1 (ko)	1997-04-08
JP2674170B2 (ja)	1997-11-12
HU204998B (en)	1992-03-30
DE3850844T2 (de)	1994-12-08
HU886266D0 (en)	1991-01-28
AU604585B2 (en)	1990-12-20
AU2623688A (en)	1989-05-23
YU47903B (sh)	1996-05-20
SE8704097D0 (sv)	1987-10-22
HUT54495A (en)	1991-03-28

Similar Documents

Publication	Publication Date	Title
CA2071408A1 (fr)	1992-12-19	Comprime matriciel permettant la liberation prolongee d'indapamine apres administration par voie orale
NO922886D0 (no)	1992-07-21	Preparat for vedvarende og styrt frigivelse av medikamentsubstans og fremgangsmaate for fremstilling av preparatet
NO914667D0 (no)	1991-11-27	Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO871790D0 (no)	1987-04-29	Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
DK367687A (da)	1988-01-19	Farmaceutisk praeparat til oral indgift med reguleret afgivelse og forlaenget virkning
NO169900C (no)	1992-08-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
FI885460L (fi)	1988-11-24	Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
NO171909C (no)	1993-05-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO892512D0 (no)	1989-06-16	Oralt preparat av buspiron og salter derav.
NO172575C (no)	1993-08-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO171857C (no)	1993-05-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO168100C (no)	1992-01-15	Analogifremgangsmaate for fremstilling av et terapeutisk aktivt fenolderivat
NO169648C (no)	1992-07-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
FI891069A7 (fi)	1989-09-09	Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten
NO169835C (no)	1992-08-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater
NO920313L (no)	1992-07-27	Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
NO172491C (no)	1993-07-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO870950L (no)	1987-09-08	Fremgangsmte for fremstilling av et stabilt injiserbart farmasytisk preparat.
NO171275C (no)	1993-02-17	Analogifremgangsmaate for fremstilling av synisomerer av terapeutisk aktive 3-cefem-4-karboksylsyrederivater med forbedrede farmakokinetika
NO167975C (no)	1992-01-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater av 3-(3-hydroksyfenyl)-1-propanonforbindelser.
NO171210C (no)	1993-02-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive indenofuran-derivater
NO167974C (no)	1992-01-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater av 3-(2-hydroksyfenyl)-1-propanonforbindelser.
SE9002067D0 (sv)	1990-06-08	The pharmacological use of certain cystine derivatives
NO903994L (no)	1988-07-15	Fremgangsmaate for fremstilling av 5-aroyl-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav.
NO171451C (no)	1993-03-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater